Cargando…
The latent period of coronavirus disease 2019 with SARS‐CoV‐2 B.1.617.2 Delta variant of concern in the postvaccination era
INTRODUCTION: Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) have resulted in new challenges for epidemic prevention and control worldwide. However, little is known about the latent period of coronavirus disease by the SARS‐CoV‐2 Delta variant of concern (VOC) in t...
Autores principales: | Ma, Tao, Ding, Songning, Huang, Rui, Wang, Hengxue, Wang, Junjun, Liu, Jiacheng, Wang, Jian, Li, Jie, Wu, Chao, Fan, Huafeng, Zhou, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186332/ https://www.ncbi.nlm.nih.gov/pubmed/35759239 http://dx.doi.org/10.1002/iid3.664 |
Ejemplares similares
-
SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
por: Lowry, Kym, et al.
Publicado: (2022) -
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021) -
Genome Sequencing of the SARS-CoV-2 Delta (B.1.617.2) Variant of Concern Detected in Bangladesh
por: Banu, Tanjina Akhtar, et al.
Publicado: (2021) -
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
por: Davis, Chris, et al.
Publicado: (2021) -
Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)